William Mattson Jr.

William Mattson Jr. General Information

Biography

Mr. William Mattson served as Operating Partner at Linden Capital Partners. Bill Mattson has spent more than 40 years in the global pharmaceutical and healthcare industry. Within that time, he spent nearly 20 years with Abbott Labs and Searle and the balance in founding and growing The Mattson Jack Group. Mr. Mattson has been involved in almost $6 billion of pharma transactions spanning branded, generic, and OTC categories. He orchestrated the out-licensing of the blockbuster drug Provigil to more than $1 billion in annual US sales and eventual sale of Labs Lafon to Cephalon for $450 million. He was involved in King Pharma's purchase of JonesPharma for $2.7 billion, Monsanto's purchase of Searle/Nutrasweet for $2.2 billion, and Bock Pharmacal's sale to Sanofi for $250 million. Mr. Mattson holds a Bachelor of Science in accounting from Bradley University and a Master of Business Administration in Marketing from Loyola University Chicago. He remains involved in education, having served on the Board of Trustees for the St. Louis College of Pharmacy.